Brief: Invivyd Announces New Pipeline Discovery Program
12/05/2025 12:12
May 12 (Reuters) - Invivyd Inc IVVD.O: INVIVYD ANNOUNCES NEW PIPELINE DISCOVERY PROGRAM FOCUSED ON MONOCLONAL ANTIBODY TREATMENT FOR MEASLES INVIVYD INC - AIMS TO IDENTIFY MEASLES MAB CANDIDATE IN 2025 Source text: ID:nGNX45Wws9 Further company coverage: IVVD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Invivyd
See all newsBrief: Invivyd Announces Positive Topline Results From Liberty Phase 3 Study Demonstrating Vyd2311 Safety And Tolerability Superior To Mrna-Based Covid-19 Vaccine Announces Regulatory Submission Plans For Vyd2311
Invivyd, Inc. reports results for the quarter ended June 30 - Earnings Summary
Invivyd Q2 loss per share comes wider than expected on higher costs
Brief: Invivyd Q2 EPS USD -0.14
Invivyd, Inc. expected to post a loss of 11 cents a share - Earnings Preview